ROLE OF TUMOR NECROSIS FACTOR ALPHA IN IMMUNE PATHOGENESIS OF DIFFERENT DISEASES AND ITS SIGNIFICANCE FOR EVOLVING ANTICYTOKINE THERAPY WITH MONOCLONAL ANTIBODIES

Tumor necrosis factor alpha (generally known as cachectin) was noted as a hallmark since the time of its discovery and still retains its position as one of the most intensely studied molecules in the field of biomedicine. TNFα is considered a prototype molecule of the family which, on the one hand,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: E. V. Voronina, N. V. Lobanova, I. R. Yakhin, N. A. Romanova, Yu. A. Seregin
Formato: article
Lenguaje:RU
Publicado: SPb RAACI 2018
Materias:
Acceso en línea:https://doaj.org/article/344ea6df6c4d4d71b6203d791ff105c8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:344ea6df6c4d4d71b6203d791ff105c8
record_format dspace
spelling oai:doaj.org-article:344ea6df6c4d4d71b6203d791ff105c82021-11-18T08:03:47ZROLE OF TUMOR NECROSIS FACTOR ALPHA IN IMMUNE PATHOGENESIS OF DIFFERENT DISEASES AND ITS SIGNIFICANCE FOR EVOLVING ANTICYTOKINE THERAPY WITH MONOCLONAL ANTIBODIES1563-06252313-741X10.15789/1563-0625-2018-6-797-806https://doaj.org/article/344ea6df6c4d4d71b6203d791ff105c82018-12-01T00:00:00Zhttps://www.mimmun.ru/mimmun/article/view/1664https://doaj.org/toc/1563-0625https://doaj.org/toc/2313-741XTumor necrosis factor alpha (generally known as cachectin) was noted as a hallmark since the time of its discovery and still retains its position as one of the most intensely studied molecules in the field of biomedicine. TNFα is considered a prototype molecule of the family which, on the one hand, plays an important role in regulating normal differentiation, growth and metabolism of various cells, and on the other hand, acts as mediator of inflammatory processes in various human diseases. Intensive interdisciplinary studies of TNFα biological role and therapeutic use have led to understanding of its polyfunctional effects and establishment of its leading role in immune pathogenesis of diseases, which was the basis for the development of “anticytokine” therapy with highly specific monoclonal antibodies. We aimed for a search of literature in the field of studying TNFα structure and properties, its role under normal conditions, in different diseases and therapy. The literature studies were performed using scientific searching systems and databases. The results are as follows: the role of tumor necrosis factor-α (TNFα) in human body in normal and pathological state was considered. Possible TNF-inducible signaling pathways, as well as existing inhibitors based on monoclonal antibodies for the treatment of rheumatoid arthritis and other autoimmune diseases are  described. In conclusion, intensive interdisciplinary studies of TNFα biological functions in normal state and diseases are still relevant today, despite huge knowledge gained on this subject.Undisputable progress in understanding the functional multiplicity of TNFα as a participant in regulation of various physiological and pathological processes in the human body has promoted development of biological agents, i.e., the tumor necrosis factor inhibitors based on monoclonal antibodies, which proved to be highly effective drugs for treatment of rheumatoid arthritis and other  diseases, thus being effective and safe biopharmaceuticals.E. V. VoroninaN. V. LobanovaI. R. YakhinN. A. RomanovaYu. A. SereginSPb RAACIarticletumor necrosis factor alphamonoclonal antibodiesinfliximabetanerceptadalimumabgolimumabcerolizumabImmunologic diseases. AllergyRC581-607RUMedicinskaâ Immunologiâ, Vol 20, Iss 6, Pp 797-806 (2018)
institution DOAJ
collection DOAJ
language RU
topic tumor necrosis factor alpha
monoclonal antibodies
infliximab
etanercept
adalimumab
golimumab
cerolizumab
Immunologic diseases. Allergy
RC581-607
spellingShingle tumor necrosis factor alpha
monoclonal antibodies
infliximab
etanercept
adalimumab
golimumab
cerolizumab
Immunologic diseases. Allergy
RC581-607
E. V. Voronina
N. V. Lobanova
I. R. Yakhin
N. A. Romanova
Yu. A. Seregin
ROLE OF TUMOR NECROSIS FACTOR ALPHA IN IMMUNE PATHOGENESIS OF DIFFERENT DISEASES AND ITS SIGNIFICANCE FOR EVOLVING ANTICYTOKINE THERAPY WITH MONOCLONAL ANTIBODIES
description Tumor necrosis factor alpha (generally known as cachectin) was noted as a hallmark since the time of its discovery and still retains its position as one of the most intensely studied molecules in the field of biomedicine. TNFα is considered a prototype molecule of the family which, on the one hand, plays an important role in regulating normal differentiation, growth and metabolism of various cells, and on the other hand, acts as mediator of inflammatory processes in various human diseases. Intensive interdisciplinary studies of TNFα biological role and therapeutic use have led to understanding of its polyfunctional effects and establishment of its leading role in immune pathogenesis of diseases, which was the basis for the development of “anticytokine” therapy with highly specific monoclonal antibodies. We aimed for a search of literature in the field of studying TNFα structure and properties, its role under normal conditions, in different diseases and therapy. The literature studies were performed using scientific searching systems and databases. The results are as follows: the role of tumor necrosis factor-α (TNFα) in human body in normal and pathological state was considered. Possible TNF-inducible signaling pathways, as well as existing inhibitors based on monoclonal antibodies for the treatment of rheumatoid arthritis and other autoimmune diseases are  described. In conclusion, intensive interdisciplinary studies of TNFα biological functions in normal state and diseases are still relevant today, despite huge knowledge gained on this subject.Undisputable progress in understanding the functional multiplicity of TNFα as a participant in regulation of various physiological and pathological processes in the human body has promoted development of biological agents, i.e., the tumor necrosis factor inhibitors based on monoclonal antibodies, which proved to be highly effective drugs for treatment of rheumatoid arthritis and other  diseases, thus being effective and safe biopharmaceuticals.
format article
author E. V. Voronina
N. V. Lobanova
I. R. Yakhin
N. A. Romanova
Yu. A. Seregin
author_facet E. V. Voronina
N. V. Lobanova
I. R. Yakhin
N. A. Romanova
Yu. A. Seregin
author_sort E. V. Voronina
title ROLE OF TUMOR NECROSIS FACTOR ALPHA IN IMMUNE PATHOGENESIS OF DIFFERENT DISEASES AND ITS SIGNIFICANCE FOR EVOLVING ANTICYTOKINE THERAPY WITH MONOCLONAL ANTIBODIES
title_short ROLE OF TUMOR NECROSIS FACTOR ALPHA IN IMMUNE PATHOGENESIS OF DIFFERENT DISEASES AND ITS SIGNIFICANCE FOR EVOLVING ANTICYTOKINE THERAPY WITH MONOCLONAL ANTIBODIES
title_full ROLE OF TUMOR NECROSIS FACTOR ALPHA IN IMMUNE PATHOGENESIS OF DIFFERENT DISEASES AND ITS SIGNIFICANCE FOR EVOLVING ANTICYTOKINE THERAPY WITH MONOCLONAL ANTIBODIES
title_fullStr ROLE OF TUMOR NECROSIS FACTOR ALPHA IN IMMUNE PATHOGENESIS OF DIFFERENT DISEASES AND ITS SIGNIFICANCE FOR EVOLVING ANTICYTOKINE THERAPY WITH MONOCLONAL ANTIBODIES
title_full_unstemmed ROLE OF TUMOR NECROSIS FACTOR ALPHA IN IMMUNE PATHOGENESIS OF DIFFERENT DISEASES AND ITS SIGNIFICANCE FOR EVOLVING ANTICYTOKINE THERAPY WITH MONOCLONAL ANTIBODIES
title_sort role of tumor necrosis factor alpha in immune pathogenesis of different diseases and its significance for evolving anticytokine therapy with monoclonal antibodies
publisher SPb RAACI
publishDate 2018
url https://doaj.org/article/344ea6df6c4d4d71b6203d791ff105c8
work_keys_str_mv AT evvoronina roleoftumornecrosisfactoralphainimmunepathogenesisofdifferentdiseasesanditssignificanceforevolvinganticytokinetherapywithmonoclonalantibodies
AT nvlobanova roleoftumornecrosisfactoralphainimmunepathogenesisofdifferentdiseasesanditssignificanceforevolvinganticytokinetherapywithmonoclonalantibodies
AT iryakhin roleoftumornecrosisfactoralphainimmunepathogenesisofdifferentdiseasesanditssignificanceforevolvinganticytokinetherapywithmonoclonalantibodies
AT naromanova roleoftumornecrosisfactoralphainimmunepathogenesisofdifferentdiseasesanditssignificanceforevolvinganticytokinetherapywithmonoclonalantibodies
AT yuaseregin roleoftumornecrosisfactoralphainimmunepathogenesisofdifferentdiseasesanditssignificanceforevolvinganticytokinetherapywithmonoclonalantibodies
_version_ 1718422341934907392